GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.55
-0.65 (-1.75%)
Mar 26, 2026, 1:08 PM CST

GeneFerm Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,5152,0001,9493,0892,7741,809
Market Cap Growth
-35.31%2.66%-36.91%11.36%53.33%122.87%
Enterprise Value
1,5592,0532,0853,1722,8421,711
Last Close Price
36.5548.2547.0072.1763.9041.33
PE Ratio
52.2169.31-24.7929.6831.51
PS Ratio
2.242.953.743.894.383.46
PB Ratio
1.862.452.473.463.342.42
P/TBV Ratio
1.862.452.483.473.342.42
P/FCF Ratio
19.9726.36-25.66--
P/OCF Ratio
15.2620.14240.8716.2322.6516.12
EV/Sales Ratio
2.303.034.004.004.483.28
EV/EBITDA Ratio
12.9317.0355.0214.4619.5814.53
EV/EBIT Ratio
33.8444.55-20.6627.8621.70
EV/FCF Ratio
20.5527.05-26.35--
Debt / Equity Ratio
0.400.400.300.140.220.59
Debt / EBITDA Ratio
2.692.695.230.561.193.52
Debt / FCF Ratio
4.274.27-1.06--
Net Debt / Equity Ratio
0.050.050.140.010.10-0.14
Net Debt / EBITDA Ratio
0.370.372.970.030.55-0.87
Net Debt / FCF Ratio
0.580.58-7.860.06-0.523.14
Asset Turnover
0.560.560.450.670.510.45
Inventory Turnover
2.732.732.643.413.202.94
Quick Ratio
2.482.481.781.250.931.50
Current Ratio
3.753.753.072.091.561.78
Return on Equity (ROE)
3.60%3.60%-2.68%14.46%11.84%10.04%
Return on Assets (ROA)
2.37%2.37%-1.85%8.12%5.09%4.29%
Return on Invested Capital (ROIC)
4.47%4.35%-3.82%13.77%11.11%10.78%
Return on Capital Employed (ROCE)
4.10%4.10%-3.40%15.60%10.70%8.90%
Earnings Yield
1.90%1.44%-1.16%4.04%3.37%3.17%
FCF Yield
5.01%3.79%-0.73%3.90%-5.62%-1.80%
Dividend Yield
---2.77%2.35%2.42%
Payout Ratio
---49.90%44.36%5.90%
Buyback Yield / Dilution
0.55%0.55%0.36%2.26%8.00%-65.83%
Total Shareholder Return
0.55%0.55%0.36%5.04%10.35%-63.41%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.